Related references
Note: Only part of the references are listed.Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options
J. C. O. Sardi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2013)
Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
Michael A. Pfaller
AMERICAN JOURNAL OF MEDICINE (2012)
Small-molecule inhibitors of biofilm formation in laboratory and clinical isolates of Candida albicans
Ariel Grald et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2012)
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance
Sonia Silva et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Candida Bloodstream Infections: Comparison of Species Distributions and Antifungal Resistance Patterns in Community-Onset and Nosocomial Isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009
Michael A. Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds
Mamiko Miyazaki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Rapid Screening Method for Compounds That Affect the Growth and Germination of Candida albicans, Using a Real-Time PCR Thermocycler
Lucja M. Jarosz et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)
Management of invasive fungal infections: a role for polyenes
Pranatharthi Chandrasekar
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms
Michael D. LaFleur et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008
M. Ortega et al.
JOURNAL OF HOSPITAL INFECTION (2011)
At What Cost Echinocandin Resistance?
Cornelius J. Clancy et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Fitness and Virulence Costs of Candida albicans FKS1 Hot Spot Mutations Associated With Echinocandin Resistance
Ronen Ben-Ami et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Organ-Specific Innate Immune Responses in a Mouse Model of Invasive Candidiasis
Michail S. Lionakis et al.
JOURNAL OF INNATE IMMUNITY (2011)
Antifungal Susceptibility and Virulence Attributes of Bloodstream Isolates of Candida from Hong Kong and Finland
C. J. Seneviratne et al.
MYCOPATHOLOGIA (2011)
Growth of Candida albicans hyphae
Peter E. Sudbery
NATURE REVIEWS MICROBIOLOGY (2011)
Small Molecule Inhibitors of the Candida albicans Budded-to-Hyphal Transition Act through Multiple Signaling Pathways
John Midkiff et al.
PLOS ONE (2011)
Epidemiology and Etiology of Denture Stomatitis
Linda Gendreau et al.
JOURNAL OF PROSTHODONTICS-IMPLANT ESTHETIC AND RECONSTRUCTIVE DENTISTRY (2011)
Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients
Emilia Siikala et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
An insight into the antifungal pipeline: selected new molecules and beyond
Luis Ostrosky-Zeichner et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
In vitro antifungal activity of hydroxychavicol isolated from Piper betle L
Intzar Ali et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2010)
Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation
Dominique Sanglard et al.
FEMS YEAST RESEARCH (2009)
Inhibitors of cellular signalling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans
Kurt A. Toenjes et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2009)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Biofilm lifestyle of Candida: a mini review
C. J. Seneviratne et al.
ORAL DISEASES (2008)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy
Morgan Hakki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans
KA Toenjes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars
Y Jin et al.
ARCHIVES OF ORAL BIOLOGY (2004)
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics
RY Kao et al.
CHEMISTRY & BIOLOGY (2004)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Denture stomatitis:: A role for Candida biofilms
G Ramage et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY (2004)
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
Biofilm-forming a ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection
Y Jin et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2003)
A novel murine model of oral candidiasis with local symptoms characteristic of oral thrush
N Takakura et al.
MICROBIOLOGY AND IMMUNOLOGY (2003)
Candida biofilms and their role in infection
LJ Douglas
TRENDS IN MICROBIOLOGY (2003)
Oral candidiasis
A Akpan et al.
POSTGRADUATE MEDICAL JOURNAL (2002)
Animal model pharmacokinetics and pharmacodynamics: a critical review
D Andes et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)
Biofilm formation by the fungal pathogen Candida albicans:: Development, architecture, and drug resistance
J Chandra et al.
JOURNAL OF BACTERIOLOGY (2001)
Virulence factors of Candida albicans
RA Calderone et al.
TRENDS IN MICROBIOLOGY (2001)
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro
J Chandra et al.
JOURNAL OF DENTAL RESEARCH (2001)
Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of disseminated candidiasis and aspergillosis
F Ikeda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
